Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|November 1, 2011
High incidence of skin rash in patients with hairy cell leukemia treated with cladribineChezi Ganzel, Moshe E Gatt, Alexander Maly, et al.
Blood Reviews|February 28, 2012
Hyperleukocytosis, leukostasis and leukapheresis: practice managementChezi Ganzel, Joanne Becker, Paul D Mintz, et al.
British Journal of Haematology|April 1, 2015
Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapyChezi Ganzel, Sean Devlin, Dan Douer, et al.
Clinical Nuclear Medicine|May 21, 2020
Posttreatment FDG-Avid Splenic Lesions in DLBCL and HD: Clinical and Radiographic Characteristics for Risk AssessmentBoaz Nachmias, Jeremy Godefroy, Eyal Rozenbach, et al.
Ejhaem|August 6, 2026
Subclinical Cardiac Changes Following CPX-351 Induction in Adults with Favorable/Intermediate-Risk AMLChezi Ganzel, Avraham Frisch, Ofir Wolach, et al.
European Journal of Haematology|December 31, 2024
Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second RemissionAvraham Frisch, Chezi Ganzel, Yishai Ofran, et al.
British Journal of Haematology|December 25, 2024
CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot studyChezi Ganzel, Avraham Frisch, Ofir Wolach, et al.
American Journal of Hematology|November 3, 2016
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapyAdir Shaulov, Chezi Ganzel, Noam Benyamini, et al.
Genes, Chromosomes & Cancer|January 25, 2019
Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16)Adrian Duek, Luba Trakhtenbrot, Ninette Amariglio, et al.
Experimental Hematology|December 24, 2021
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatmentAriella Tvito, Aaron Ronson, Renan Ghosheh, et al.
Pageof 5